Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 201-083-8 | CAS number: 78-10-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Repeated dose toxicity: inhalation
Administrative data
- Endpoint:
- short-term repeated dose toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- not specified
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
Data source
Reference
- Reference Type:
- publication
- Title:
- No-effect level of subacute tetraethoxysilane inhalation on the mouse kidney.
- Author:
- Omae K, Nakashima H, Takebayashi T, Uemura T, Ishizuka C, Yamazaki K, Sakurai H
- Year:
- 1 995
- Bibliographic source:
- Journal of occupational health, 37(1): pp. 1-4; Jan 1995.
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 412 (Subacute Inhalation Toxicity: 28-Day Study)
- Deviations:
- yes
- Remarks:
- limited examinations, males only, limited information on exposure conditions.
- GLP compliance:
- not specified
- Limit test:
- no
Test material
- Reference substance name:
- Tetraethyl orthosilicate
- EC Number:
- 201-083-8
- EC Name:
- Tetraethyl orthosilicate
- Cas Number:
- 78-10-4
- Molecular formula:
- C8H20O4Si
- IUPAC Name:
- tetraethyl orthosilicate
Constituent 1
Test animals
- Species:
- mouse
- Strain:
- ICR
- Remarks:
- SPF grade
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Japan, Inc.
- Age at study initiation: Four weeks
- Weight at study initiation: Not specified
- Fasting period before study: Not specified
- Housing: Five per transparent plastic cages with stainless steel wire mesh ceiling
- Diet (e.g. ad libitum): Pelleted rodent food (CRF-1), ad libitum
- Water (e.g. ad libitum): Distilled water, ad libitum
- Acclimation period: One week
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22
- Humidity (%): 60
- Air changes (per hr): Not specified, filtered air, ventilated
- Photoperiod (hrs dark / hrs light): 12/12
IN-LIFE DATES: Not specified
Administration / exposure
- Route of administration:
- inhalation: vapour
- Type of inhalation exposure:
- whole body
- Vehicle:
- other: unchanged (no vehicle)
- Details on inhalation exposure:
- GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Chamber: Tightly sealed 500 Lstainless steel exposure chamber
- Tetraethyl orthosilicate was supplied from an organic solvent vapour generator
TEST ATMOSPHERE
- Brief description of analytical method used: GC
- Samples taken from breathing zone: Not specified - Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- monitored at 10 minute intervals by means of GC
- Duration of treatment / exposure:
- 6 hours/day for 2 or 4 weeks
- Frequency of treatment:
- 5 days/week
Doses / concentrationsopen allclose all
- Dose / conc.:
- 50 ppm (analytical)
- Dose / conc.:
- 100 ppm (analytical)
- No. of animals per sex per dose:
- 10M
- Control animals:
- other: filtered room air
- Details on study design:
- - Dose selection rationale: Not specified
- Rationale for animal assignment (if not random): Not specified
- Rationale for selecting satellite groups: No satellite groups
- Post-exposure recovery period in satellite groups: No post-exposure recovery period - Positive control:
- None
Examinations
- Observations and examinations performed and frequency:
- CAGE SIDE OBSERVATIONS: Yes
- Time schedule: Behaviour and external appearance checked daily
DETAILED CLINICAL OBSERVATIONS: No
BODY WEIGHT: Yes
- Time schedule for examinations: Weighed on Monday, Wednesday, and Friday prior to exposure
FOOD CONSUMPTION: No
FOOD EFFICIENCY: No
WATER CONSUMPTION: No
OPHTHALMOSCOPIC EXAMINATION: No
HAEMATOLOGY: Yes
- Time schedule for collection of blood: Not specified
- Anaesthetic used: Not specified
- Animals fasted: Not specified
- How many animals: Not specified
- Parameters checked in Table 1 below were determined
CLINICAL CHEMISTRY: Yes
- Time schedule for collection of blood: Not specified
- Animals fasted: Not specified
- How many animals: Not specified
- Parameters checked in Table 1 below were determined
URINALYSIS: Yes
- Time schedule for collection of urine: Every Friday night
- Metabolism cages used for collection of urine: Yes
- Animals fasted: Not specified
- Parameters checked in Table 1 below were determined
NEUROBEHAVIOURAL EXAMINATION: No - Sacrifice and pathology:
- SACRIFICE
The mice were sacrificed by exsanguination 2 days after the final exposure.
GROSS PATHOLOGY: Yes
As described, their organs were examined grossly.
HISTOPATHOLOGY: Yes
The tissues identified in Table 2 below were subjected to microscopic examination.
- Statistics:
- Student's t test or Welch's methods were adopted for the statistical test of difference between means of the effects indices.
Results and discussion
Results of examinations
- Clinical signs:
- no effects observed
- Description (incidence and severity):
- Immediately after being exposed on each day, most mice began to perform face-washing movements and lick the lower abdomen for short periods more frequently than non-exposed mice. Finding is considered non-adverse.
- Mortality:
- no mortality observed
- Body weight and weight changes:
- no effects observed
- Description (incidence and severity):
- No differences were observed between the exposed and non-exposed groups in body weight gain.
- Food consumption and compound intake (if feeding study):
- not examined
- Food efficiency:
- not examined
- Water consumption and compound intake (if drinking water study):
- not examined
- Ophthalmological findings:
- not examined
- Haematological findings:
- effects observed, treatment-related
- Description (incidence and severity):
- RBC, Hb and Ht values were lower in exposed mice than in non-exposed mice, mixed statistical results (see Table 3 below). The proportion of neutrophils were significantly higher at 50 and 100 ppm in the 2-week study, but not in the 4-week. The neutrophil count (not shown) was significantly higher at 100 ppm in the 4-week study.
- Clinical biochemistry findings:
- no effects observed
- Urinalysis findings:
- no effects observed
- Behaviour (functional findings):
- not examined
- Organ weight findings including organ / body weight ratios:
- no effects observed
- Description (incidence and severity):
- Kidney weights were slightly lower at 50 and 100 ppm, after 2- or 4-weeks of exposure (not significant). No trends reported for lung, liver, or spleen weight.
- Gross pathological findings:
- no effects observed
- Description (incidence and severity):
- “Organs were examined,” but no findings reported.
- Histopathological findings: non-neoplastic:
- effects observed, treatment-related
- Description (incidence and severity):
- In the kidney, 2/10 mice exposed to 100 ppm for 2 weeks and 2/10 mice exposed to 100 ppm for 4 weeks developed histopathological lesions (tubulo-interstitial nephritis). The lesions were wedge-shaped and extended from the cortex into the medulla. In the affected regions, small numbers of neutrophils and mononuclear inflammatory cells had infiltrated interstitial tissue, and some tubules were dilated, exhibiting atrophy and obliteration. No kidney lesions were observed in mice exposed to 50 ppm.
Inflammation of the nasal mucosa was observed in almost all the mice (9/10 to 10/10) exposed to 50 ppm or 100 ppm, for 2 or 4 weeks. Exudates containing inflammatory cells and necrotic epithelial cells were observed in the nasal cavity, inflammatory cell infiltration in submucosal tissue, and eosinophilic hyaline droplets predominantly in the olfactory epithelium. The findings were slightly more severe in the mice exposed to 100 ppm.
In the bone marrow, increases in the M: E ratio were observed, no further details provided.
No lesions were observed in the liver, lungs, respiratory tract, spleen, pancreas, thymus, thyroid, or cornea.
Effect levels
- Key result
- Dose descriptor:
- NOAEC
- Effect level:
- < 50 ppm (analytical)
- Based on:
- test mat.
- Sex:
- male
- Basis for effect level:
- other: Nasal cavity histopathology (inflammation) and haematology findings, noting renal histopathology at 100 ppm
Target system / organ toxicity
open allclose all
- Key result
- Critical effects observed:
- yes
- Lowest effective dose / conc.:
- 100 ppm (analytical)
- System:
- urinary
- Organ:
- kidney
- Treatment related:
- yes
- Key result
- Critical effects observed:
- yes
- Lowest effective dose / conc.:
- 50 ppm (analytical)
- System:
- respiratory system: upper respiratory tract
- Organ:
- nasal cavity
- Treatment related:
- yes
Any other information on results incl. tables
Concentrations of tetraethyl orthosilicate (Mean +/- SD):
Exposure level of 100 ppm:
2 weeks: 100 +/- 4
4 weeks: 101 +/- 5
Exposure level of 50 ppm:
2 weeks: 51 +/- 3
4 weeks: 51 +/- 3
Table 3 Summary of haematological findings following two and four weeks exposure.
Exposure Concentration (ppm) | Two week exposure | Four week exposure | ||||
100 | 50 | 0 | 100 | 50 | 0 | |
RBC (x10000/µ l) | 823± 60* | 866± 51 | 895± 60 | 840± 39 | 815± 36* | 859± 35 |
Hg (g/dl) | - | - | - | 14.1± 0.5* | 13.7± 0.5** | 14.7± 0.6 |
Ht (%) | 42.9± 3.2** | 45.1± 2.7 | 47.5± 3.2 | 43.1± 1.4 | 42.3± 1.6** | 44.6± 1.8 |
WBC (x100 µ l) | - | - | - | 36± 13 | 21± 6 | 28± 14 |
Neutrophil (%) | 30± 10** | 27± 5* | 13± 7 | 34± 9 | 24± 11 | 25± 18 |
Lymphocyte (%) | 68± 10** | 72± 5** | 85± 7 | 64± 9 | 75± 12 | 74± 19 |
Table 4 Number of mice with significant histopathological findings on the kidney and nasal cavity.
Exposure concentration (ppm) | 100 | 50 | 0 | |||
Exposure duration | 2 | 4 | 2 | 4 | 2 | 4 |
Kidney TIN | 2 | 2 | 0 | 0 | 0 | 0 |
Nasal cavity | ||||||
SIN | 10 | 10 | 7 | 10 | 0 | 0 |
All positive findings | 10 | 10 | 9 | 10 | 0 | 0 |
TIN: tubulo-interstitial nephritis.
SIN: submucosal infiltration of neutrophilic leukocytes.
Applicant's summary and conclusion
- Conclusions:
- In the key repeated inhalation study which was similar to OECD 412 (no information on GLP status), the LOAEC for tetraethyl orthosilicate was 50 ppm vapour (ca. 0.4 mg/L) in male mice after a 2- or 4-week exposure, based primarily on histopathological (inflammatory) findings in the nasal mucosa and with some haematological changes noted. Histopathology findings in the kidney were observed at 100 ppm (ca. 0.9 mg/L) when mice were exposed over 2 or 4 weeks. Kidney weights were slightly lower at 50 and 100 ppm after 2 or 4 weeks, but this renal result was not significant. A NOAEC is not identified. The published study is well documented, meets generally accepted scientific principles, is acceptable for assessment, and thus is assigned reliability score 2.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
